Publishing in a subscription based journal
Introduction
Ectrodactyly/split-hand foot malformation (SHFM) can occur as an isolated abnormality but is also associated with more than 100 syndromes [Elliott and Evans 2006; Elliott et al., 2005] .
At least 7 different genetic loci have been mapped [de Mollerat et al., 2003; Elliott and Evans 2006; Faiyaz-Ul-Haque et al., 2005; Goodman et al., 2002; Ianakiev et al., 2000; Naveed et al., 2006; Scherer et al., 1994; Ugur and Tolun 2008] . Acinar dysplasia (Congenital Pulmonary Airway Malformation (CPAM) type 0) is a rare perinatal lethal congenital lung disease [Chow et al., 2013; Lee 2013] . It is the rarest subtype of CPAM and is characterized embryologically by maturational arrest of the lung at the pseudo-glandular stage of development [Chow et al., 2013] . Familial cases of acinar dysplasia have been described and some reports describe associated congenital abnormalities. The etiology of acinar dysplasia is unknown [Lee 2013 ]. The combination of acinar dysplasia and ectrodactyly has not been described before.
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Fibroblast growth factor receptor (FGFR2) (OMIM 176943) is a tyrosine kinase receptor and is one of four FGF receptors which have roles in the development and homeostasis of various tissues and the regulation of metabolism [Goetz and Mohammadi 2013] . When bound by a fibroblast growth factor (FGF), FGFR2 monomers dimerize resulting in transphosphorylation of tyrosine residues in the phosphotyrosine kinase domain. This activates the kinase activity of this receptor leading to the phosphorylation of intracellular targets [Goetz and Mohammadi 2013] . Fibroblast Receptor substrate 2 alpha (FRS2) (OMIM 607743), a target of FGFR2, lies immediately downstream of the receptor and mediates signaling through the MAP Kinase pathway [Gotoh et al., 2004; Gotoh et al., 2005] . ERK1/ERK2 (MAPK3/MAPK1, respectively), two components of this pathway, become phosphorylated when FGFR2 is activated and can traffic to the nucleus where they mediate effects of receptor activation. In the nucleus, they phosphorylate relevant targets, thereby promoting cellular proliferation and other events [Meister et al., 2013] . The ligand binding extracellular portion of FGFR2 is comprised of three immunoglobulin-like domains (D1, D2 and D3) [Goetz and Mohammadi 2013] . Alternative splicing of the C-terminal portion of the D3 domain determines ligand specificity. FGFR2 exists in two major isoforms (IIIb and IIIc), each of which has had the Cterminal end of the D3 domain encoded by a different exon. IIIb is expressed specifically in epithelial cells whilst IIIc is expressed in mesenchymal tissues [Eswarakumar et al., 2005] .
FGFR2-associated disease is most often due to mutations in the IIIc isoform. Activating mutations in FGFR2 cause Crouzon syndrome (OMIM 123500) , Apert syndrome (OMIM 101200) [Wilkie et al., 1995] , Pfeiffer syndrome (OMIM 101600) [Muenke et al., 1994; Schell et al., 1995] , Jackson-Weiss syndrome (OMIM 123150) [Jabs et al., 1994] , Beare-Stevenson syndrome (OMIM 123790) [Przylepa et al., 1996] , and nonsyndromic craniosynostosis [Carinci et al., 2005; Wilkie et al., 2007] .
The majority of mutations in Crouzon syndrome occur in the D3 domain. Several of these This article is protected by copyright. All rights reserved. 6 craniosynostosis syndromes have associated limb abnormalities (e.g. broad first finger/toe in Pfeiffer syndrome, syndactyly in Apert syndrome), but ectrodactyly is not a general feature of these conditions [Garcin et al., 1932] ectrodactyly and the absence of craniosynostosis in the affected infant, her heterozygous parents and her sibling, led to our hypothesis that the FGFR2 mutation in this family is at least a partial loss-of-function mutation. We performed functional experiments to determine the effect of the p.R255Q mutation on the activity of FGFR2 by measuring its effect on downstream signaling and to confirm whether FGFR2 is expressed in the tissues involved in the phenotype of the affected infant. In silico modeling was also carried out to predict the impact of the p.R255Q mutation. This is the first instance of a homozygous FGFR2 missense mutation causing disease in humans.
Materials and Methods

SNP Array Analysis
DNA from peripheral blood to identify copy number changes and regions of loss of heterozygosity due to consanguinity.
Whole Exome Sequencing (WES)
Whole exome capture (Agilent Whole Exome SureSelect V4 All Exon Capture Platform;
Agilent Technologies, Mulgrave, Victoria Australia) and sequencing (Illumina HiSeq2000 platform; Illumina, Inc, San Diego, CA USA), targeting a total sequence of 51 MB were performed at the Australian Genome Research Facility (Parkville, Victoria). Samples were sequenced using a paired end 2 x100 sequencing protocol. Reads were mapped to hg19 and variants called and annotated as described previously [Gagliardi et al., 2014] . Variants from within regions of common descent were screened against dbSNP v135 and Exome Aggregation Consortium (ExAC, v0.3.1, http://exac.broadinstitute.org) databases. Filtering was carried out on the WES variants under the key assumptions that the disease is completely penetrant and that any variants present in the affected infant, which were also present in dbSNP v135 with a minor allele frequency (MAF) greater than 0.1%, were non-causative, and hence excluded. Homozygous variants within regions of loss of heterozygosity were preferentially considered to fit with the predicted autosomal recessive mode of inheritance.
Variants then underwent SeattleSeq Annotation including Genomic Evolutionary Rate
Profiling (GERP) [Cooper et al., 2005] and were screened using PolyPhen-2 and Combined Annotation Dependent Depletion (CADD, v1.3) [Kircher et al., 2014 ] to predict pathogenicity. Primers were designed to amplify regions containing top hit candidate SNVs from patient, parents and an unaffected sibling DNA, and Sanger sequencing was performed to confirm their presence and segregation.
Candidate Gene Expression Using in situ RNA Hybridization
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The candidate genes were annotated with a locus specific database (Mouse Genome Informatics (MGI), Online Mendelian disease database (OMIM) and gene expression databases (GenePaint and BioGPS). Whole mount in situ RNA hybridizations were performed on the limbs of E11.5 and E12.5 embryonic C57BL/6 inbred mice according to a previously published method on the Intavis InsituPro VSi instrument in order to determine the expression pattern of FGFR2 during digital development [Riddle et al., 1993] . These stages were chosen as development of the digits begins to take place during these times [Taher et al., 2011] . RNA in situ probes were designed to target the final exon junction in 
Generation of FGFR2 WT and Mutant Expression Constructs
A pRcCMV plasmid expressing the mesenchymal isoform FGFR2 IIIc (NM_000141.4, NP_000132.3, transcript variant 1) (pRcCMV-FGFR2) was purchased from OriGene. Using site-directed mutagenesis, we generated pRcCMV-FGFR2(p.R255Q) and pRcCMV-FGFR2(C342Y) (a mutation causing constitutive receptor activation) and pRcCMV-Empty.
FGFR2 and ERK1/2 Phosphorylation Assays
Human 
Results
Clinical Details
The proband was born to healthy first cousin parents of Kurdish heritage; the mother was 20 years old and the father 23 years old. There was no history of infertility or miscarriages. Firsttrimester nuchal translucency and biochemical screening were normal. Ultrasound examination at 19 weeks gestation revealed abnormalities of the hands and feet. On the left hand the thumb, second, third and fourth fingers were short and the fifth was thought to be absent. On the right hand only the index finger was seen. The arm bones appeared to be normal on both sides. On both feet, only the first and fifth toe could be identified. In addition to the limb abnormalities, there was evidence of echogenicity of the fetal gut. Parental hemoglobin electrophoresis and alpha thalassemia genotyping were normal. The couple was counselled regarding the differential diagnosis for these abnormalities, declined amniocentesis and elected to continue the pregnancy. The female infant was born at 36 weeks gestation following spontaneous onset of labour. Birthweight was 2.3 kg (15 th percentile).
The infant was in poor condition at birth (Apgar 2 1 4 5 ) and required immediate ventilatory support for severe respiratory distress. Chest x-ray was consistent with severe pulmonary hypoplasia and ventilatory support was withdrawn at 5 hours of age; the infant died shortly after. Dysmorphic facial features were noted with epicanthic folds, a small mouth (23 mm, normal range 26 ± 2.5 mm), mild hypertelorism (78 mm, normal range 65 ± 3.5 mm), a broad nasal bridge and bulbous nasal tip, low set ears and obvious narrowing of the external auditory canals bilaterally which remained patent ( Figure 1A and B). The fontanelles were normal and there were no features to suggest craniosynostosis. Both parents had normal physical examinations. X-ray of the mother's skull showed no abnormalities (Supp. Figure   S1 ).
There were 4 digits on the left hand and a cleft extending into the palm between fingers 2 and 3 ( Figure 1C , D and H). There was skin syndactyly between fingers 1 and 2, and fingers 3 and 4. Fingers 1-3 were considerably shorter than the fourth finger. There was no recognizable thumb. Only one digit was recognizable on the right hand and this digit was attached to a broad base ( Figure 1E and 1J). There were 4 digits identifiable on the right foot with the appearance of a bifid first toe and a cleft extending into the dorsum of the right foot between the bifid first/second toe and toes 4 and 5 ( Figure 1F ). There were 4 recognizable digits on the left foot including a large first toe (not shown). There was syndactyly between the second and third toes on this foot and a cleft between the first and second toes. These limb abnormalities were thought to represent a severe form of ectrodactyly with both oligodactyly and syndactyly. X-rays of the hands ( Figure 1G corresponding to Figure 1H , and Figure 1I corresponding to Figure 1J ) and feet performed at autopsy confirmed a disorganized pattern with absent or short phalanges, variable degrees of syndactyly, ectrodactyly, oligodactyly and bifid bones. Skeletal radiological survey was otherwise normal with no abnormalities of the cranial vault. The lungs were small at autopsy (combined weight 26.89 g; normal for 36 week female 36.7± 16.8 g) and had abnormal lobation with 2 lobes on the right and one on the left ( Figure 1K ). Histological examination demonstrated severe maturational arrest of lung tissue at the pseudoglandular stage and multiple small cysts of <0.5 cm in diameter consistent with a diagnosis of acinar dysplasia ( Figure 1L and 1M).
SNP Array and Whole Exome Sequencing to Identify Causal Candidate Gene
Mutations
No significant copy number changes were identified in the genome of the affected infant using SNP array. There were however long continuous stretches of homozygosity representing approximately 6% of the genome, consistent with the degree of consanguinity expected for offspring of first cousins.
Whole exome sequencing (WES) was then performed on the affected infant, and following removal of variants present at a MAF>0.1% in dbSNP v135, coding variants were identified in 21 genes within the regions of loss of heterozygosity (LOH). These were further filtered to remove unlikely pathogenic variants with PolyPhen2 (benign), GERP (<2) and CADD (<10) using SeattleSeq Annotation which further narrowed down the number to 13 candidate variants on both parents, the affected infant and her sibling using Sanger sequencing was consistent with autosomal recessive inheritance of the disease for all variants except for SPATA13 which was homozygous in the unaffected sibling and hence was excluded.
Of the 4 remaining genes, the mutation in FGFR2 (p.R255Q; Table 1 ) was considered to be the most likely causative gene based on Online Mendelian Inheritance in Man (OMIM) phenotypes, expression data (BioGPS), a FGFR2 mouse model [Mai et al., 2010] , in silico modeling, and functional studies (outlined below). Sanger sequencing of each family member for segregation of FGFR2 (p.R255Q) is shown in Figure 2A and B. Variants in GGA3, COL12A1 and UBE2Q2 were excluded as candidates due to clinical, phenotypic and/or expression inconsistencies when compared to the affected individual (Table 1) .
FGFR2 Expression Marks Tissues Affected in this Patient
To more clearly define the expression profile of FGFR2 in developing limbs and lungs, we performed in situ RNA hybridization on a staged series of mouse embryos. FGFR2 expression was seen in the developing limbs at day E11.5 and E12.5. At E11.5, there was strong expression in the hindlimbs and forelimbs, specifically in mesenchymal condensations that will later give rise to bone ( Figure 3A ). By E12.5, FGFR2 expression was localized to the webbing between the developing digits in the forelimbs and hindlimbs, tissues consistent with the aberrant development seen in the patient. Expression was also seen in the developing epithelium of E14.5 lungs which is consistent with the defects associated with acinar dysplasia ( Figure 3B ).
An Important Role for R255 in the Protein -in silico Modeling
The wildtype R255 amino acid residue in FGFR2 and its surrounding sequence is highly conserved across multiple species including chimpanzee, mouse, chicken and zebrafish, and in all human FGFR family members ( Figure 4A and Supp. Figure S2 ). The p.R255Q variant is situated at the D3 domain end of the linker between domains D2 and D3 ( Figure 4B ), and within a hotspot of germline mutations that cause Crouzon and Apert syndromes and nonsyndromic craniosynostosis ( Figure 4C ). R255 with H254 and I348 forms a pocket for the binding of a sulfate ion from heparan sulphate ( Figure 4D , top), [Golovin et al., 2005; Stauber et al., 2000] a glycoprotein that facilitates high affinity binding of the FGF ligand to the FGFR2 receptor [Plotnikov et al., 2000] which is a necessary for active signaling from the cytoplasmic receptor tyrosine kinase [Stauber et al., 2000] .
The p.R255Q mutation likely
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FGFR2 (p.R255Q) Displays Loss-Of-Function Properties
To ascertain the functional effect of the p.R255Q mutation on FGFR2 signaling, we measured phosphorylation of FGFR2 and its downstream effectors ERK1/2 in response to the activating ligand FGF2. Phosphorylation of 2 tyrosine residues (Y653 and Y654) in the activation loop of FGFR2 leads to activation and signaling of the receptor [Eswarakumar et al., 2005] . As a positive control, we included a known Crouzon syndrome mutation C342Y, which causes homodimerization and constitutive activation of FGFR2 resulting in increased basal ERK1/2 phosphorylation [Krejci et al., 2012] . 
Discussion
This case of a unique phenotype of ectrodactyly and acinar dysplasia represents the first human case of homozygous FGFR2 disease to the best of our knowledge. RNA in situ hybridization data revealed expression in the affected tissues in mice (forelimbs, hindlimbs and the lung) and protein alignments revealed a high level of conservation for the R255
residue. Fgfr2 knockout mice show complete absence of limb outgrowth and defects in lung branching morphogenesis [Arman et al., 1999] . Further, a homozygous knock-in mouse model of a gain-of-function Fgfr2 W290R mutant developed by others overlaps most of the abnormalities observed in our patient [Mai et al., 2010] . Interestingly however, while Consistent with loss-of-function of FGFR2 in our patient causing lung and limb abnormalities is phenotypic data from a mouse model of homozygous loss-of-function mutation in FGF10, an endogenous ligand of FGFR2 [Sekine et al., 1999] . In this study, homozygous FGF10-deficient mice died at birth due to lack of lung development. Severe pulmonary branching morphology was disrupted. Mutant mice also had complete truncation of the fore-and
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hindlimbs [Sekine et al., 1999] . Based on genetic inheritance pattern, functional studies, and our patient and parental phenotypes, we propose that the homozygous FGFR2 mutation is most likely a loss-of-function. FGF2 stimulation assays showed that this mutation displays decreased but not completely abrogated activation and signaling in downstream pathways, providing evidence of at least partial loss-of-function. Furthermore, segregation analysis supports the candidacy of this gene and in situ RNA hybridization in mice point to the involvement of this gene in limb and lung development. Further functional work will be required to confirm the exact mechanism by which this gene mutation leads to loss-offunction of FGFR2.
Gain-of-function mutations in FGFR2 have consistently caused craniosynostosis syndromes [Hatch et al., 2006] . These gain-of-function mutations in craniosynostosis syndromes are thought to do so through receptor activation and some are glycosylation-dependent [Hatch et al., 2006] . In our study, we provide evidence that the FGFR2 p.R255Q mutation is at least partial loss-of-function. Neither parent has evidence of craniosynostosis on physical examination; the mother has had a skull x-ray with no evidence of craniosynostosis and both the father and the heterozygous sibling have no evidence of craniosynostosis. Similarly, dominant activating mutations in FGFR3 cause a variety of short-limbed bone dysplasias including achondroplasia and syndromic craniosynostosis. But recently, WES identified a homozygous loss-of-function mutation in FGFR3 in humans characterized by tall stature and severe skeletal abnormalities leading to inability to walk, with camptodactyly, arachnodactyly, and scoliosis [Makrythanasis et al., 2014] .
Somatic loss-of-function mutations in FGFR2 are associated with malignant melanoma, but no previous cases of germline FGFR2 loss-of-function mutations have been described [Gartside et al., 2009] . The combination of acinar dysplasia with ectrodactyly has not been previously reported although there is one report of ectrodactyly and capillary alveolar [Sen et al., 2013] . FOXF1 is expressed in developing capillaries rather than developing epithelium. It is interesting that germline mutations in Crouzon syndrome and somatic mutations in endometrial cancer have been shown to be gain-of-function while somatic mutations in melanoma are loss-of-function [Gartside et al., 2009] . For these three conditions, there are no mutations in common although they are somewhat scattered linearly along the primary protein sequence. Hence, for any newly identified variant, it may be very difficult to predict its phenotypic impact without functional testing.
Here we report a novel germline FGFR2 mutation which displays yet another phenotype, and which is flanked immediately by Crouzon syndrome mutations. In our unique case, we have identified a homozygous at least partial loss-of-function mutation in FGFR2 associated with a severe phenotype including lethal lung disease and marked limb abnormalities. 
